Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst ...

ABC News' Dr. Tara Narula breaks down the FDA's decision to stop the making of compound versions of weight loss medications.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Increasing access to these effective evidence-based treatments would benefit our society as a whole, not just those impacted ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Drugs like Ozempic have a positive impact on weight loss, though only for a short period, with long-term health implications ...